Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion
Neuro-Oncology · 2023
DOI: 10.1093/neuonc/noac186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Ann T Chen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Yale University, New Haven, CT, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Glioma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Improved treatment of glioblastoma (GBM) needs to address tumor invasion, a hallmark of the disease that remains poorly understood. In this study, we profiled GBM invasion through integrative analysis of histological and single-cell RNA sequencing (scRNA-seq) data from 10 patients.
Methods
Human histology samples, patient-derived xenograft mouse histology samples, and scRNA-seq data were collected from 10 GBM patients. Tumor invasion was characterized and quantified at the phenotypic level using hematoxylin and eosin and Ki-67 histology stains. Crystallin alpha B (CRYAB) and CD44 were identified as regulators of tumor invasion from scRNA-seq transcriptomic data and validated in vitro, in vivo, and in a mouse GBM resection model.
Results
At the cellular level, we found that invasive GBM are less dense and proliferative than their non-invasive counterparts. At the molecular level, we identified unique transcriptomic features that significantly contribute to GBM invasion. Specifically, we found that CRYAB significantly contributes to postoperative recurrence and is highly co-expressed with CD44 in invasive GBM samples.
Conclusions
Collectively, our analysis identifies differentially expressed features between invasive and nodular GBM, and describes a novel relationship between CRYAB and CD44 that contributes to tumor invasiveness, establishing a cellular and molecular landscape of GBM invasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
- Department of Neurosurgery, Yale University, New Haven, CT, USA.
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
- Department of Pathology, Yale University, New Haven, CT, USA.
- Department of Statistics, Columbia University, New York, NY, USA.
ORCID-Profile: Jiangbing Zhou
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- NCATS NIH HHS
- NIH
Zitieren
APA
Chen, A. T., Xiao, Y., Tang, X., Baqri, M., Gao, X., Reschke, M., Sheu, W. C., Long, G., Zhou, Y., Deng, G., Zhang, S., Deng, Y., Bai, Z., Kim, D., Huttner, A., Kunes, R., Günel, M., Moliterno, J., Saltzman, W. M., …, & Zhou, J. (2023). Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion. Neuro-Oncology. https://doi.org/10.1093/neuonc/noac186
Vancouver
Chen AT, Xiao Y, Tang X, Baqri M, Gao X, Reschke M, et al. Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion. Neuro-Oncology. 2023. doi:10.1093/neuonc/noac186
BibTeX
@article{Chen2023,
author = {Chen, Ann T and Xiao, Yang and Tang, Xiangjun and Baqri, Mehdi and Gao, Xingchun and Reschke, Melanie and Sheu, Wendy C and Long, Gretchen and Zhou, Yu and Deng, Gang and Zhang, Shenqi and Deng, Yanxiang and Bai, Zhiliang and Kim, Dongjoo and Huttner, Anita and Kunes, Russell and Günel, Murat and Moliterno, Jennifer and Saltzman, W Mark and Fan, Rong and Zhou, Jiangbing},
title = {Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion},
journal = {Neuro-Oncology},
year = {2023},
doi = {10.1093/neuonc/noac186}
}
EUVIMED